Entero Therapeutics
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of Entero Therapeutics generated cash of -$12,377,852, which is more than the previous year. Cash used in financing activities reached the amount of $15,226,721 last year. Net change in cash is therefore $2,348,869.
Cash Flow
| 2015 | -4.17K | -24 | 4.68K |
|---|---|---|---|
| 2017 | -7.18M | -32.16K | 6.01M |
| 2019 | -14.03K | -24 | 13.14K |
| 2022 | -22.34M | 0 | 15.73M |
| 2023 | -12.37M | -500K | 15.22M |
ENTO Cash Flow Statement (2015 – 2023)
| 2023 | 2022 | 2019 | 2017 | 2015 | |
|---|---|---|---|---|---|
Cash at beginning of period | 1.38M | 8.24M | 1.11K | 1.77M | 133 |
Operating activities | |||||
Net income | -15.79M | -14.62M | -15.17K | -11.09M | -5.93K |
| Adjustments to reconcile net income to cash generated by operating activities: | |||||
Depreciation and amortization | 29.27K | 29.27K | 635 | 753.99K | 733 |
Stock-based compensation expense | 1.04M | 769.12K | 1.39K | 2.01K | 0 |
| Deferred income tax benefit | 1.04M | 769.12K | 1.39K | 2.01K | 0 |
| Changes in operating assets and liabilities: | |||||
Accounts receivable, net | 93.01K | -93 | -749 | 3.43K | -638 |
Inventories | 0 | 0 | 0 | 0 | 0 |
Accounts payable | -165.76K | -1.98M | -420.78K | -233.77K | 0 |
Cash generated by operating activities | -12.37M | -22.34M | -14.03K | -7.18M | -4.17K |
Investing activities | |||||
Purchases Of Investments | 0 | 0 | 0 | 0 | 0 |
Investments In Property Plant And Equipment | -500K | 0 | -24.09K | -32.16K | -24 |
Acquisitions Net | 0 | 0 | 0 | 0 | 0 |
Cash generated by investing activities | -500K | 0 | -24 | -32.16K | -24 |
Financing activities | |||||
Common Stock Issued | 15.82M | 23.04M | 9.47M | 5.00M | 0 |
Payments for dividends | 0 | 0 | 0 | 0 | 0 |
Repurchases of common stock | 0 | 0 | 0 | 0 | 0 |
Repayments of term debt | -603.49K | -641.23K | 3.60M | 1.00M | 5.02M |
Cash used in financing activities | 15.22M | 15.73M | 13.14K | 6.01M | 4.68K |
Net Change In Cash | 2.34M | -6.86M | -938 | -1.20M | 447 |
Cash at end of period | 3.73M | 1.38M | 175 | 573.47K | 581 |